Stroke is a leading cause of disability worldwide, and brain injuries devastate patients and
their families, but currently no drugs on the market promote neurological recovery. Limited …

Extracellular vesicles (EVs) are submicron-sized lipid envelopes that are produced and
released from a parent cell and can be taken up by a recipient cell. EVs are capable of …

Over 700 drugs have failed in stroke clinical trials, an unprecedented rate thought to be
attributed in part to limited and isolated testing often solely in “young” rodent models and …

Extracellular vesicles (EVs) have been recognized as an evolving biomarker within the
liquid biopsy family. While carrying both host cell proteins and different types of RNAs, EVs …

Previously thought to be nothing more than cellular debris, extracellular vesicles (EVs) are
now known to mediate physiological and pathological functions throughout the body. We …

Exosomes are a subset of extracellular vesicles released by all cell types and involved in
local and systemic intercellular communication. In the past decade, research into exosomes …

The brain has many connections with various organs. Recent advances have demonstrated
the existence of a bidirectional central nervous system (CNS) and intestinal tract, that is, the …

Recent work has indicated that photobiomodulation (PBM) may beneficially alter the
pathological status of several neurological disorders, although the mechanism currently …

Alzheimer's disease (AD) is a progressive neurodegenerative brain pathology and the most
common form of dementia. Evidence suggests that extracellular vesicles (EVs) containing …

Stroke is the world's leading cause of disability with limited brain repair treatments which
effectively improve long‐term neurological deficits. The neuroinflammatory responses …